Clinical Trials
3 trialsNCT05183139 2022-05-03
US MM-7
Takeda
Phase 4 Withdrawn
NCT01410929 2017-01-20
MM
Merit Medical Systems, Inc.
Phase 4 Withdrawn
NCT00242528 2015-04-14
Open-label Study, to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Bone Lesions Secondary to Multiple Myeloma.
Novartis
Phase 4 Withdrawn